Compare NetEase Inc (NTES) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NetEase Inc vs Smith & Nephew plc — how do they compare? NetEase Inc trades at $123.01 (market cap $82.75B), while Smith & Nephew plc trades at $29.78 (market cap $12.54B). The key difference: NetEase Inc is far larger — about 6.6× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.65%). Which is the better fit depends on your goals.
| NTES | SNN | |
|---|---|---|
Market Cap | $82.75B | $12.54B |
Sector | Media | Health |
52-Week High | $159.34 | $38.70 |
52-Week Low | $109.26 | $28.73 |
Enterprise Value | $59.05B | $15.57B |
Dividend Yield | 2.36% | 2.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NetEase (NTES) trades at $133.41, up 0.9% with bullish technical signals and strong fundamentals. The stock shows robust profitability with 29.84% net margins and 22.12% ROE, supported by consistent revenue growth to $112.63B in 2025. Recent Q1 2026 earnings beat expectations at $2.53 EPS versus $2.19 forecast. Technical analysis indicates bullish momentum with support at $131 and resistance at $135, while analyst consensus remains strongly positive with 82% buy ratings.
Outlook remains favorable given strong cash flow generation ($50.74B operating cash flow) and international expansion potential. Key risks include Chinese regulatory environment and competitive pressures. With attractive valuation at 16.31 P/E and bullish institutional sentiment, NTES presents growth opportunity though investors should monitor earnings consistency and market volatility.
Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.
Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
